Figure 5. Abundance (LSM ± SEM) of transcripts for inducible nitric oxide synthase (iNOS), chemokine (C-C motif) ligand 5 (CCL5),β-defensin (DEFB) 3, DEFB4, DEFB5, DEFB7, DEFB10, IL-1β (IL1B), and IL-8 (IL8) in CD11b+CD14+ (macrophages) and CD11b+CD14−(neutrophils) cells from milk of quarters treated with the control (CNTRL), 100 μg of 25-hydroxyvitamin D3 (25D), 5 μg of lipopolysaccharide(LIPO), and 5 μg of LPS in combination with 100 μg of 25-hydroxyvitamin D3 (LIPO+25D); n = 5/treatment. Transcript abundances areexpressed relative to RPS9 transcript abundance at 8 h postchallenge. *P < 0.05, **P < 0.01, ***P < 0.001; relative transcript abundancesdiffered from CNTRL. P-values for main effects of treatments and treatment interactions are provided in Table 3.